IDO1 and breast carcinoma: Indirectly related, transcription factor-dependent IDO expression mediates the immunosuppressive effect of MDSCs in a breast cancer model, with IDO blockade leading to the inhibition of effector T cell response and improvement in disease-related outcomes [99,100].